Related Experiment Video
Updated: Jun 18, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Predictors of Developing Heart Failure in Adults with Congenital Heart Defects
Kambiz Norozi1,2,3,4, Matthias J Müller2, Chuce Xing1
1Department of Pediatrics, Pediatric Cardiology, Western University, London, ON N6A 3K7, Canada.
Insights
Adults with congenital heart defects (ACHD) are at high risk for heart failure (HF). A combination of exercise capacity, NT-proBNP levels, and QRS duration can predict HF development in ACHD patients.
Area of Science:
- Cardiology
- Adult Congenital Heart Disease (ACHD)
- Heart Failure (HF)
Background:
- The population of adults with congenital heart defects (ACHD) is growing, with heart failure (HF) being the leading cause of premature death.
- Limited information exists on predictive factors for HF in ACHD patients, highlighting a critical knowledge gap.
Purpose of the Study:
- To re-examine a cohort of ACHD patients after a 15-year follow-up period.
- To identify and evaluate predictors for the development of HF in ACHD patients.
Main Methods:
- A follow-up study involving 249 adults with repaired or palliated congenital heart defects (CHD) initially studied in 2003.
- Investigated the predictive value of maximum oxygen uptake (VO2 max), N-terminal pro brain natriuretic peptide (NT-proBNP), and QRS complex duration for HF development.
Main Results:
- Significant predictors for HF development included NT-proBNP levels >1.7 times the upper normal limit, VO2 max <73% of predicted values, and QRS duration >120 ms.
- The combination of these three parameters demonstrated a high predictive value (AUC = 0.75) for HF development.
Conclusions:
- The combination of VO2 max, NT-proBNP, and QRS duration effectively predicts HF development in ACHD patients over 15 years.
- Enhanced surveillance of these parameters in ACHD patients may aid in HF prevention and early intervention.
Background:
The population of adults with congenital heart defects (ACHD) is growing. The leading cause of premature death in these patients is heart failure (HF). However, there is still limited information on the predictive factors for HF in ACHD patients.
Objectives:
This study re-examined a group of patients with repaired or palliated congenital heart defects (CHD) that were initially studied in 2003. A follow-up period of 15 years has allowed us to identify and evaluate predictors for the development of HF in ACHD.
Methods:
All patients with repaired or palliated CHD who participated in the initial study (n = 364) were invited for a follow-up examination. The effects of maximum oxygen uptake ( ) during exercise stress testing, the cardiac biomarker N-terminal pro brain natriuretic peptide (NT-proBNP), and QRS complex on the development of HF during the follow-up period were investigated.
Results:
From May 2017 to April 2019, 249 of the initial 364 (68%) patients participated in the follow-up study. Of these, 21% were found to have mild CHD, 60% had moderate CHD, and 19% had complex CHD. Significant predictors for the development of HF were: NT-proBNP level 1.7 times the upper normal limit, 73% of predicted values, and QRS complex duration 120 ms. Combination of these three parameters resulted in the highest area-under-the-curve of 0.75, with a sensitivity of 75% and specificity of 63% for predicting the development of HF.
Conclusions:
In this cohort of ACHD patients, the combination of , NT-proBNP, and QRS duration was predictive of HF development over a 15-year follow-up period. Enhanced surveillance of these parameters in patients with ACHD may be beneficial for the prevention of HF and early intervention.
Related Concept Videos
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Cardiac Performance
Heart Failure Drugs: Diuretics

